Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · IEX Real-Time Price · USD
6.69
+0.62 (10.21%)
At close: Mar 28, 2024, 4:00 PM
6.50
-0.19 (-2.84%)
After-hours: Mar 28, 2024, 6:43 PM EDT

Aprea Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
21.6528.7953.0889.02130.0965.6824.4
Cash & Cash Equivalents
21.6528.7953.0889.02130.0965.6824.4
Cash Growth
-24.80%-45.76%-40.38%-31.57%98.08%169.15%-
Other Current Assets
0.871.373.513.42.960.320.33
Total Current Assets
22.5230.1556.5892.42133.046624.73
Property, Plant & Equipment
0.0900.210.360.560.020.03
Other Long-Term Assets
0.0400.030.03000
Total Long-Term Assets
0.1300.240.390.560.020.03
Total Assets
22.6530.1656.8292.81133.6166.0224.76
Accounts Payable
1.670.841.774.52.181.741.66
Deferred Revenue
0.53000000
Current Debt
000.190.260.2400
Other Current Liabilities
2.192.365.3510.576.643.132.64
Total Current Liabilities
4.393.27.3215.339.064.874.3
Long-Term Debt
0000.080.300
Other Long-Term Liabilities
1.311.3100000
Total Long-Term Liabilities
1.311.3100.080.300
Total Liabilities
5.74.517.3215.419.364.874.3
Total Debt
000.190.340.5400
Debt Growth
---43.17%-38.50%---
Retained Earnings
-308.08-293.8-181.13-144.01-90.53-62.47-46.94
Comprehensive Income
-10.61-10.62-10.36-10.04-11.53-8.76-8.29
Shareholders' Equity
16.9525.6449.5177.4124.24-51.44-35.77
Net Cash / Debt
21.6528.7952.8988.68129.5465.6824.4
Net Cash / Debt Growth
-24.80%-45.57%-40.37%-31.54%97.25%169.15%-
Net Cash Per Share
5.9817.3749.6983.93431.631137.88423.25
Working Capital
18.1426.9549.2777.09123.9861.1320.43
Book Value Per Share
4.6915.4746.5273.24413.97-891.16-620.35
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).